7bd61add的个人主页 - 老虎社区

7bd61add

暂无个人介绍

IP属地：未知

5关注

15粉丝

0主题

0勋章

2021-12-10

Lai liao cpi 6.8%

Toplines Before US Market Open on Friday

2021-12-10

So 7%

What to Watch Out For in the Inflation Numbers

2021-12-09

$Fortinet(FTNT)$ zscaler up 3%. Hello ftnt follow your industry and get lifted together

2021-12-08

$Tesla Motors(TSLA)$ tesla is now grandmother stock

2021-12-08

$Fortinet(FTNT)$ zs up so much today. Follow your sector please :)

2021-12-08

$Walt Disney(DIS)$spiderman no way home

2021-12-08

Any third party can verify their claims though?

Pfizer, BioNTech say third dose neutralizes Omicron variant

2021-12-02

$Sea Ltd(SE)$ 8 days to cover? Will there be a short squeeze then? 🤔

2021-12-01

$Sea Ltd(SE)$the move down similar to FTNT & ZS. Same industry meh?

2021-11-30

$Applied Materials(AMAT)$textbook breaking out of consolidation with retrace + bounce off resistance turned support

2021-11-23

$Meta Platforms, Inc.(FB)$is it going to hold?

2021-11-22

$Roblox Corporation(RBLX)$ run!!

2021-11-22

$Meta Platforms, Inc.(FB)$ roblox and meta etf are diving

2021-11-22

$Meta Platforms, Inc.(FB)$ why are institutions selling? Take profit?

2021-11-19

$Meta Platforms, Inc.(FB)$ at support level of channel, time to bounce!

2021-11-18

$NVIDIA Corp(NVDA)$Keybanc analyst John Vinh maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Piper Sandler analyst Harsh Kumar maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Mizuho analyst Vijay Rakesh maintained Nvidia with a Buy rating and raised the price target from $235 to $335.Raymond James analyst Chris Caso maintained Nvidia with a Strong Buy rating and raised the price target from $225 to $365.Needham analyst Rajvindra Gill maintained Nvidia with a Buy rating and raised the price target from $245 to $400.Truist Securities analyst William Stein maintained Nvidia with a Buy rating and raised the price target from $360 to $389.

2021-11-18

$NVIDIA Corp(NVDA)$ 330 tonight

2021-11-17

$Meta Platforms, Inc.(FB)$test 350 tonight?

2021-11-15

$Fortinet(FTNT)$many stop losses are likely filled time for the v shape rebound

2021-11-15

$Meta Platforms, Inc.(FB)$time to complete inverse h&s tonight. Spring up let's go!

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3579088083036701","uuid":"3579088083036701","gmtCreate":1615997387503,"gmtModify":1638995121099,"name":"7bd61add","pinyin":"selltoofast","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":15,"headSize":5,"tweetSize":92,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"93.90%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"93.59%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":605834272,"gmtCreate":1639143268621,"gmtModify":1639143268798,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"Lai liao cpi 6.8%","listText":"Lai liao cpi 6.8%","text":"Lai liao cpi 6.8%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605834272","repostId":"1115031273","repostType":2,"repost":{"id":"1115031273","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639143317,"share":"https://www.laohu8.com/m/news/1115031273?lang=&edition=full","pubTime":"2021-12-10 21:35","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1115031273","media":"Tiger Newspress","summary":"Stock-market index trade higher after inflation report.\nAt 8:34 a.m. ET, Dow e-minis were up 176 poi","content":"<p>Stock-market index trade higher after inflation report.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 176 points, or 0.49%, S&amp;P 500 e-minis were up 30.75 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.</p>\n<p><img src=\"https://static.tigerbbs.com/022d770c8d408fcc5c7a5267e1fa96a1\" tg-width=\"412\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p>\n<p>Inflation accelerated at its fastest pace since 1982 in November, the Labor Department said Friday, putting pressure on the economic recovery and raising the stakes for the Federal Reserve.</p>\n<p>The consumer price index, which measures the cost of a wide-ranging basket of goods, rose 0.8% for the month, good for a 6.8% pace on a year over year basis and the fastest rate since June 1982.</p>\n<p>Excluding food and energy prices, so-called core CPI was up 0.5% for the month and 4.9% from a year ago, which itself was the sharpest pickup since mid-1991.</p>\n<p>The Dow Jones estimate was for a 6.7% annual gain for headline CPI and 4.9% for core.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Tesla(TSLA)</b>&nbsp;–&nbsp;Tesla Inc&nbsp;Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.He also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.Tesla shares dropped more&nbsp;than&nbsp;1% in premarket trading.</p>\n<p><b>Oracle(ORCL) </b>– Oracle shares surged 12% in the premarket, after quarterly sales and revenue beat estimates and the business software company announced a $10 billion increase in its share repurchase program.&nbsp;Oracle earned an adjusted $1.21 per share, 10 cents above estimates, with particular strength for its cloud infrastructure business.</p>\n<p><b>Broadcom(AVGO)</b> – The chip maker’s shares rallied nearly 7% in premarket trading after it beat Street forecasts on the top and bottom lines for its latest quarter.&nbsp;Broadcom earned an adjusted $7.81 per share, 7 cents above estimates, and also issued an upbeat forecast on continued high demand from its cloud computing customers.</p>\n<p><b>Chewy(CHWY) </b>– The online pet products retailer’s stock tumbled 10% in the premarket after it reported a wider-than-expected quarterly loss.&nbsp;Sales were in line with Street forecasts, but profit was impacted by higher costs for labor and supply chain issues.</p>\n<p><b>Moderna(MRNA)</b>&nbsp;–&nbsp;Moderna&nbsp;shares&nbsp;plunged&nbsp;10%&nbsp;in premarket trading.Other vaccine stocks also fell.BioNTech&nbsp;fell&nbsp;more&nbsp;than&nbsp;5%,Novavax&nbsp;fell&nbsp;more&nbsp;than&nbsp;3%.</p>\n<p><b>Lululemon(LULU)</b> – The athletic apparel maker reported adjusted quarterly profit of $1.62 per share, 21 cents above estimates, with revenue slightly above forecasts as well.&nbsp;However, Lululemon also warned that new Covid-19 variants could impact demand for “athleisure” clothing if virus concerns lead to temporary store closures and further supply chain issues.&nbsp;The stock slid 1.3% in premarket action.</p>\n<p><b>C3Ai(AI)</b> – The artificial intelligence software company’s stock soared 20% in the premarket after it won a $500 million contract from the U.S. Department of Defense for its suite of AI products.</p>\n<p><b>Costco(COST)</b> – The warehouse retailer earned $2.98 per share for its latest quarter, compared with a consensus estimate of $2.64, with revenue topping Street forecasts as well.&nbsp;The beat came despite higher costs and supply chain issues that Costco said it was able to largely mitigate.&nbsp;Costco rose 1.8% in the premarket.</p>\n<p><b>Beyond Meat(BYND)</b> – Restaurant chain Taco Bell dropped plans to test Beyond Meat’s plant-based version of carne asada,according to a Bloomberg report.&nbsp;Taco Bell is said to have been dissatisfied with samples it received in October, although the companies continue to work together on new products.&nbsp;Beyond Meat slipped 1.6% in premarket trading.</p>\n<p><b>American Outdoor Brands(AOUT)</b> – The outdoor products maker reported adjusted quarterly profit of 58 cents per share, well below the 76 cent consensus estimate, with revenue also falling short of analyst forecasts.&nbsp;The company said sales slowed due to a shift in customer purchase timing into the prior quarter to lessen supply chain concerns.&nbsp;American Outdoor shares plummeted 19% in premarket action.</p>\n<p><b>Vail Resorts(MTN)</b> – The resort operator lost $3.44 per share for its latest quarter, smaller than the loss of $3.62 that analysts had anticipated, thanks to a jump in season pass sales.&nbsp;However, revenue was below estimates.</p>\n<p><b>Peloton(PTON)</b> – The fitness equipment maker’s shares lost 3.6% in the premarket after Credit Suisse downgraded the stock to “neutral” from “outperform”.&nbsp;The firm noted a number of headwinds for Peloton, including a return to out-of-home fitness and a shift in consumer spending.</p>\n<p><b>AMC Entertainment(AMC)</b> – The movie theater operator’s shares slid 1% in premarket trading, after SEC filings showed a sale of 312,500 shares by CEO Adam Aron and a sale of 18,000 shares by CFO Sean Goodman.&nbsp;Aron had indicated in November that he would soon begin selling shares as part of estate planning.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stock-market index trade higher after inflation report.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 176 points, or 0.49%, S&amp;P 500 e-minis were up 30.75 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.</p>\n<p><img src=\"https://static.tigerbbs.com/022d770c8d408fcc5c7a5267e1fa96a1\" tg-width=\"412\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p>\n<p>Inflation accelerated at its fastest pace since 1982 in November, the Labor Department said Friday, putting pressure on the economic recovery and raising the stakes for the Federal Reserve.</p>\n<p>The consumer price index, which measures the cost of a wide-ranging basket of goods, rose 0.8% for the month, good for a 6.8% pace on a year over year basis and the fastest rate since June 1982.</p>\n<p>Excluding food and energy prices, so-called core CPI was up 0.5% for the month and 4.9% from a year ago, which itself was the sharpest pickup since mid-1991.</p>\n<p>The Dow Jones estimate was for a 6.7% annual gain for headline CPI and 4.9% for core.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Tesla(TSLA)</b>&nbsp;–&nbsp;Tesla Inc&nbsp;Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.He also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.Tesla shares dropped more&nbsp;than&nbsp;1% in premarket trading.</p>\n<p><b>Oracle(ORCL) </b>– Oracle shares surged 12% in the premarket, after quarterly sales and revenue beat estimates and the business software company announced a $10 billion increase in its share repurchase program.&nbsp;Oracle earned an adjusted $1.21 per share, 10 cents above estimates, with particular strength for its cloud infrastructure business.</p>\n<p><b>Broadcom(AVGO)</b> – The chip maker’s shares rallied nearly 7% in premarket trading after it beat Street forecasts on the top and bottom lines for its latest quarter.&nbsp;Broadcom earned an adjusted $7.81 per share, 7 cents above estimates, and also issued an upbeat forecast on continued high demand from its cloud computing customers.</p>\n<p><b>Chewy(CHWY) </b>– The online pet products retailer’s stock tumbled 10% in the premarket after it reported a wider-than-expected quarterly loss.&nbsp;Sales were in line with Street forecasts, but profit was impacted by higher costs for labor and supply chain issues.</p>\n<p><b>Moderna(MRNA)</b>&nbsp;–&nbsp;Moderna&nbsp;shares&nbsp;plunged&nbsp;10%&nbsp;in premarket trading.Other vaccine stocks also fell.BioNTech&nbsp;fell&nbsp;more&nbsp;than&nbsp;5%,Novavax&nbsp;fell&nbsp;more&nbsp;than&nbsp;3%.</p>\n<p><b>Lululemon(LULU)</b> – The athletic apparel maker reported adjusted quarterly profit of $1.62 per share, 21 cents above estimates, with revenue slightly above forecasts as well.&nbsp;However, Lululemon also warned that new Covid-19 variants could impact demand for “athleisure” clothing if virus concerns lead to temporary store closures and further supply chain issues.&nbsp;The stock slid 1.3% in premarket action.</p>\n<p><b>C3Ai(AI)</b> – The artificial intelligence software company’s stock soared 20% in the premarket after it won a $500 million contract from the U.S. Department of Defense for its suite of AI products.</p>\n<p><b>Costco(COST)</b> – The warehouse retailer earned $2.98 per share for its latest quarter, compared with a consensus estimate of $2.64, with revenue topping Street forecasts as well.&nbsp;The beat came despite higher costs and supply chain issues that Costco said it was able to largely mitigate.&nbsp;Costco rose 1.8% in the premarket.</p>\n<p><b>Beyond Meat(BYND)</b> – Restaurant chain Taco Bell dropped plans to test Beyond Meat’s plant-based version of carne asada,according to a Bloomberg report.&nbsp;Taco Bell is said to have been dissatisfied with samples it received in October, although the companies continue to work together on new products.&nbsp;Beyond Meat slipped 1.6% in premarket trading.</p>\n<p><b>American Outdoor Brands(AOUT)</b> – The outdoor products maker reported adjusted quarterly profit of 58 cents per share, well below the 76 cent consensus estimate, with revenue also falling short of analyst forecasts.&nbsp;The company said sales slowed due to a shift in customer purchase timing into the prior quarter to lessen supply chain concerns.&nbsp;American Outdoor shares plummeted 19% in premarket action.</p>\n<p><b>Vail Resorts(MTN)</b> – The resort operator lost $3.44 per share for its latest quarter, smaller than the loss of $3.62 that analysts had anticipated, thanks to a jump in season pass sales.&nbsp;However, revenue was below estimates.</p>\n<p><b>Peloton(PTON)</b> – The fitness equipment maker’s shares lost 3.6% in the premarket after Credit Suisse downgraded the stock to “neutral” from “outperform”.&nbsp;The firm noted a number of headwinds for Peloton, including a return to out-of-home fitness and a shift in consumer spending.</p>\n<p><b>AMC Entertainment(AMC)</b> – The movie theater operator’s shares slid 1% in premarket trading, after SEC filings showed a sale of 312,500 shares by CEO Adam Aron and a sale of 18,000 shares by CFO Sean Goodman.&nbsp;Aron had indicated in November that he would soon begin selling shares as part of estate planning.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AOUT":"American Outdoor Brands, Inc.",".IXIC":"NASDAQ Composite","COST":"好市多",".DJI":"道琼斯","LULU":"lululemon athletica","MTN":"Vail Resorts Inc","AI":"C3.ai, Inc.","BNTX":"BioNTech SE","ORCL":"甲骨文","AMC":"AMC院线",".SPX":"S&P 500 Index","BYND":"Beyond Meat, Inc.","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","AVGO":"博通","CHWY":"Chewy, Inc.","TSLA":"特斯拉","PTON":"Peloton Interactive, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115031273","content_text":"Stock-market index trade higher after inflation report.\nAt 8:34 a.m. ET, Dow e-minis were up 176 points, or 0.49%, S&P 500 e-minis were up 30.75 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.\n\nInflation accelerated at its fastest pace since 1982 in November, the Labor Department said Friday, putting pressure on the economic recovery and raising the stakes for the Federal Reserve.\nThe consumer price index, which measures the cost of a wide-ranging basket of goods, rose 0.8% for the month, good for a 6.8% pace on a year over year basis and the fastest rate since June 1982.\nExcluding food and energy prices, so-called core CPI was up 0.5% for the month and 4.9% from a year ago, which itself was the sharpest pickup since mid-1991.\nThe Dow Jones estimate was for a 6.7% annual gain for headline CPI and 4.9% for core.\nStocks making the biggest moves premarket:\nTesla(TSLA) – Tesla Inc Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.He also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.Tesla shares dropped more than 1% in premarket trading.\nOracle(ORCL) – Oracle shares surged 12% in the premarket, after quarterly sales and revenue beat estimates and the business software company announced a $10 billion increase in its share repurchase program. Oracle earned an adjusted $1.21 per share, 10 cents above estimates, with particular strength for its cloud infrastructure business.\nBroadcom(AVGO) – The chip maker’s shares rallied nearly 7% in premarket trading after it beat Street forecasts on the top and bottom lines for its latest quarter. Broadcom earned an adjusted $7.81 per share, 7 cents above estimates, and also issued an upbeat forecast on continued high demand from its cloud computing customers.\nChewy(CHWY) – The online pet products retailer’s stock tumbled 10% in the premarket after it reported a wider-than-expected quarterly loss. Sales were in line with Street forecasts, but profit was impacted by higher costs for labor and supply chain issues.\nModerna(MRNA) – Moderna shares plunged 10% in premarket trading.Other vaccine stocks also fell.BioNTech fell more than 5%,Novavax fell more than 3%.\nLululemon(LULU) – The athletic apparel maker reported adjusted quarterly profit of $1.62 per share, 21 cents above estimates, with revenue slightly above forecasts as well. However, Lululemon also warned that new Covid-19 variants could impact demand for “athleisure” clothing if virus concerns lead to temporary store closures and further supply chain issues. The stock slid 1.3% in premarket action.\nC3Ai(AI) – The artificial intelligence software company’s stock soared 20% in the premarket after it won a $500 million contract from the U.S. Department of Defense for its suite of AI products.\nCostco(COST) – The warehouse retailer earned $2.98 per share for its latest quarter, compared with a consensus estimate of $2.64, with revenue topping Street forecasts as well. The beat came despite higher costs and supply chain issues that Costco said it was able to largely mitigate. Costco rose 1.8% in the premarket.\nBeyond Meat(BYND) – Restaurant chain Taco Bell dropped plans to test Beyond Meat’s plant-based version of carne asada,according to a Bloomberg report. Taco Bell is said to have been dissatisfied with samples it received in October, although the companies continue to work together on new products. Beyond Meat slipped 1.6% in premarket trading.\nAmerican Outdoor Brands(AOUT) – The outdoor products maker reported adjusted quarterly profit of 58 cents per share, well below the 76 cent consensus estimate, with revenue also falling short of analyst forecasts. The company said sales slowed due to a shift in customer purchase timing into the prior quarter to lessen supply chain concerns. American Outdoor shares plummeted 19% in premarket action.\nVail Resorts(MTN) – The resort operator lost $3.44 per share for its latest quarter, smaller than the loss of $3.62 that analysts had anticipated, thanks to a jump in season pass sales. However, revenue was below estimates.\nPeloton(PTON) – The fitness equipment maker’s shares lost 3.6% in the premarket after Credit Suisse downgraded the stock to “neutral” from “outperform”. The firm noted a number of headwinds for Peloton, including a return to out-of-home fitness and a shift in consumer spending.\nAMC Entertainment(AMC) – The movie theater operator’s shares slid 1% in premarket trading, after SEC filings showed a sale of 312,500 shares by CEO Adam Aron and a sale of 18,000 shares by CFO Sean Goodman. Aron had indicated in November that he would soon begin selling shares as part of estate planning.","news_type":1},"isVote":1,"tweetType":1,"viewCount":666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605376625,"gmtCreate":1639123301077,"gmtModify":1639123301752,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"So 7%","listText":"So 7%","text":"So 7%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605376625","repostId":"1139831281","repostType":4,"repost":{"id":"1139831281","pubTimestamp":1639121338,"share":"https://www.laohu8.com/m/news/1139831281?lang=&edition=full","pubTime":"2021-12-10 15:28","market":"us","language":"en","title":"What to Watch Out For in the Inflation Numbers","url":"https://stock-news.laohu8.com/highlight/detail?id=1139831281","media":"Bloomberg","summary":"For the first time in a long while, they’re coming out on a Friday. And they’ll matter a lot more th","content":"<p>For the first time in a long while, they’re coming out on a Friday. And they’ll matter a lot more than payrolls.</p>\n<p><img src=\"https://static.tigerbbs.com/7c00a863d083ec338ea2add1af36990e\" tg-width=\"1400\" tg-height=\"836\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Roll Over Non-Farm Payrolls (and Tell Tchaikovsky the News)</b></p>\n<p>The rhythms of markets are disconcertingly fixed and settled. For years now, the monthly “Payrolls Friday” has been part of my life. Payrolls data is often flawed and subject to huge revisions, but it’s an accepted ritual that it really, really matters. Traders are ready and poised at 8:30 on a Friday morning waiting for the numbers that will determine a messy final day’s trading for the week.</p>\n<p>We are about to witness a change to the established order. Unemployment has mattered more than inflation for at least a generation. Price rises have been broadly under control and much less has hung on each announcement. And in any case, there’s less of a ritual around the CPI numbers. They come out on different days of the week, often clashing with earnings announcements and other big market events. It just doesn’t have the same place in the firmament.</p>\n<p>But this month, for the first time in ages, inflation numbers are coming out on a Friday. And in another change to the established order,&nbsp;they matter a lot more than the unemployment numbers. Inflation is back, and nobody knows how long it’s going to stay. There is also the chance of a big round number, as some estimates put the headline rate of inflation above 7%. That’s unheard of&nbsp;since 1984.</p>\n<p>The consensus estimate is a tad lower, but it’s a fair bet that the initial reaction will be binary, just as the first response on unemployment data day is usually driven by whether the change in non-farm payrolls is above or below expectations. If it’s above 7%, there will be an instant risk-off move, while anything below it will probably spark relief.</p>\n<p>But that’s only for the very short term. After the first seconds of seeing the headline number, we’ll all have an immense amount of data to digest, which can be sliced and diced more or less any way you like. The numbers,&nbsp;coming ahead of a raft of central bank meetings next week, could have profound effects. This month, CPI Friday really should be a much bigger deal than NFP Friday.</p>\n<p>Here are a few points to help get ready:</p>\n<p><b>The Labor Market Gives No Reason for Emergency Measures</b></p>\n<p>Inflation is so important for gauging central banks’ reaction because there is now literally no reason at all to maintain emergency monetary measures for the sake of the labor market. This week’s figures on initial claims for unemployment insurance in the U.S. showed the fewest&nbsp;people signing on in more than 50 years. Adding in continued claims, the numbers on unemployment insurance are almost down to their level immediately before the pandemic.&nbsp;You have to go back to 1973 for the last time claims were lower than that:</p>\n<p><img src=\"https://static.tigerbbs.com/80e2b8046480f2bc043a5dbd6fa8e638\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\"></p>\n<p>Meanwhile, data on job openings, known as JOLTS,&nbsp;show more vacancies than at any time since the survey started 20 years ago. Companies seem to be having little success filling them, implying&nbsp;much greater negotiating strength for workers in wage bargaining:</p>\n<p><img src=\"https://static.tigerbbs.com/52e5eb3bea0bf21f5913394dd91842f0\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\"></p>\n<p>On that subject, the Atlanta Fed’s Wage Growth Tracker, based on census data, shows the fastest overall wage growth since 2007. But it’s lower than core consumer price inflation, so workers have an incentive to push for more:</p>\n<p><img src=\"https://static.tigerbbs.com/9444eea2896b80cd322178e442f38921\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\"></p>\n<p>Meanwhile, the details from the wage tracker&nbsp;report suggest that historic changes are afoot in the labor market, with the youngest and lowest&nbsp;paid finally having the leverage to secure higher “compensation” while the best&nbsp;paidand over-55s are getting a worse deal than usual.</p>\n<p><img src=\"https://static.tigerbbs.com/21b717fb57cd9596864424c1dc5c07ad\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/b19f0eb1e3d04479c7560d6452deb027\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\"></p>\n<p>In short, the labor market suggests that the Fed should be reducing stimulus. Higher inflation would ram that home.</p>\n<p><b>From Now On, Base Effects Should Be Our Friends</b></p>\n<p>If inflation does top 7%, remember that that figurereally could be transitory. The high headline numbers at present are driven partly&nbsp;by low base effects from 12 months ago, and the odds are heavily skewed toward&nbsp;those&nbsp;effects soon starting to turn positive. To cite the most important example, this is what has happened to year-on-year gasoline inflation over the last 16 years:</p>\n<p><img src=\"https://static.tigerbbs.com/43481748b9f92ff5a6414eec5fd97d6b\" tg-width=\"971\" tg-height=\"552\" referrerpolicy=\"no-referrer\"></p>\n<p>Gasoline prices are not going to keep increasing at more than 50% per annum. As the chart shows, the chances are that before long, they’ll be decreasing year-on-year and helping to lower&nbsp;headline inflation.</p>\n<p>Looking at commodity prices more generally, they tend to drive producer price inflation, for obvious reasons. And the broad-based Bloomberg Commodity Index has been declining of late:</p>\n<p><img src=\"https://static.tigerbbs.com/b32bc3bc1f7bdbcaf9df114fe9adeb10\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\"></p>\n<p>None of this means that inflation will zoom back down to 2% in short order. But it does imply that the headline numbers are very likely to fall a bit before they rise. There’s currently little reason to expect sustained inflation of more than 7%.</p>\n<p><b>Peak Bottleneck Is Here, Perhaps</b></p>\n<p>Another critical driver of this inflation spike has of course been the global interruption to supply chains. Bottlenecks have driven prices far higher by&nbsp;constricting supply. Restrictions to global transport remain extreme, but they&nbsp;seem to be peaking. In the following heat map, Moody’s Investors Service&nbsp;handily collated a number of measures of shipping rates. Most at least seem to have started to decline a little from the peak:</p>\n<p><img src=\"https://static.tigerbbs.com/e22919eb213adb8d4723178130e2cc17\" tg-width=\"2172\" tg-height=\"671\" referrerpolicy=\"no-referrer\"></p>\n<p>Conducting a similar exercise for global manufacturing and trade activity is also a little reassuring. U.S. manufacturers as a whole are in expansion mode, and railroad volumes are improving. However, semiconductor shipments have yet&nbsp;to show sustained improvement, and car production in the U.S. and Germany has been slowed as a result:</p>\n<p><img src=\"https://static.tigerbbs.com/1c366469943d74b4973492509674d12c\" tg-width=\"2136\" tg-height=\"581\" referrerpolicy=\"no-referrer\"></p>\n<p>The semiconductor shortage made itself felt most in the motor industry at first, but as this chart from Gavekal Research shows, it appears to have moved on to smartphones. Smartphone sales are running slightly below their level a year ago:</p>\n<p><img src=\"https://static.tigerbbs.com/65ff2bafedd90fcbb4457fa2b511f1cf\" tg-width=\"679\" tg-height=\"510\" referrerpolicy=\"no-referrer\"></p>\n<p>None of this is reason to relax. There is still a serious supply chain problem across the world, and a new Covid variant might yet bring it back in full force. But it does look reasonable to say that this is about as bad as it will get, and that the worst might already&nbsp;be behind us. It’s certainly reasonable to expect that bottleneck resolution should be a downward pressure on inflation next year, just as they drove inflation upward&nbsp;in 2021.</p>\n<p>So, a 7% inflation print would not be the end of the world, nor would it last forever. Bear that in mind at 8:30 a.m., New York time.</p>\n<p><b>Exciting Times for Actuaries</b></p>\n<p>The last two years have sent the actuarial profession rushing back in time. The industry had its birth in the Victorian era, to offer help dealing with the pressing risk that you might die too soon. Over the decades, medical progress helped make that risk easier and cheaper to protect against. But increasing longevity led to a new and even more difficult problem —&nbsp;the risk of living too long. For at least the last generation, actuaries have been preoccupied with the intractable task of guaranteeing a growing and aging population an income in retirement. The steady fall in bond yields has made this much harder by raising the price of buying a fixed income.</p>\n<p>2020 and 2021 have changed the pattern. The American Council of Life Insurers has published its annual survey of the total death benefit payments paid out by life insurers&nbsp;last year. The rise&nbsp;was the greatest in more than a century —&nbsp;although still far below the horrific increase in&nbsp;1918, year of the Spanish Flu pandemic:</p>\n<p><img src=\"https://static.tigerbbs.com/93d02f5264c0e5e00ae991d49bb9985a\" tg-width=\"1132\" tg-height=\"646\" referrerpolicy=\"no-referrer\"></p>\n<p>This does help&nbsp;confirm that the Covid pandemic did have real and tangible effect on public health, something that&nbsp;some people still doubt.</p>\n<p>If the job of insuring lives grew a little harder, the job of assuring a pension grew easier. Rising share prices, making assets greater, combined with a rise in bond yields (making liabilities cheaper)&nbsp;to improve their funding position dramatically. Mercer, the actuarial group, published monthly estimates of the pension deficits of companies in the S&amp;P 500 which offer defined benefit plans.</p>\n<p>The numbers involved are huge.Mercer estimates&nbsp;that the&nbsp;aggregate value of pension plan assets of the S&amp;P&nbsp;1500 companies as of Oct.&nbsp;31&nbsp;was $2.32&nbsp;trillion, compared with estimated aggregate liabilities of $2.44&nbsp;trillion. Corporate pensions’ assets are now enough to cover 94% of their liabilities; an uncomfortable position, but a great relief after their funding status had dropped below 70% in the aftermath of the financial crisis:</p>\n<p><img src=\"https://static.tigerbbs.com/0812dd33e90114fe505751c5bc0dfe9d\" tg-width=\"953\" tg-height=\"775\" referrerpolicy=\"no-referrer\"></p>\n<p>Pension fund actuaries are also among the small but important group of people who would welcome higher bond yields. Amid&nbsp;difficult times, it’s encouraging that the looming pension crisis might yet resolve itself naturally.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What to Watch Out For in the Inflation Numbers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat to Watch Out For in the Inflation Numbers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 15:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/opinion/articles/2021-12-10/inflation-numbers-grab-spotlight-from-payrolls-in-biggest-shift-in-decades?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For the first time in a long while, they’re coming out on a Friday. And they’ll matter a lot more than payrolls.\n\nRoll Over Non-Farm Payrolls (and Tell Tchaikovsky the News)\nThe rhythms of markets are...</p>\n\n<a href=\"https://www.bloomberg.com/opinion/articles/2021-12-10/inflation-numbers-grab-spotlight-from-payrolls-in-biggest-shift-in-decades?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bloomberg.com/opinion/articles/2021-12-10/inflation-numbers-grab-spotlight-from-payrolls-in-biggest-shift-in-decades?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139831281","content_text":"For the first time in a long while, they’re coming out on a Friday. And they’ll matter a lot more than payrolls.\n\nRoll Over Non-Farm Payrolls (and Tell Tchaikovsky the News)\nThe rhythms of markets are disconcertingly fixed and settled. For years now, the monthly “Payrolls Friday” has been part of my life. Payrolls data is often flawed and subject to huge revisions, but it’s an accepted ritual that it really, really matters. Traders are ready and poised at 8:30 on a Friday morning waiting for the numbers that will determine a messy final day’s trading for the week.\nWe are about to witness a change to the established order. Unemployment has mattered more than inflation for at least a generation. Price rises have been broadly under control and much less has hung on each announcement. And in any case, there’s less of a ritual around the CPI numbers. They come out on different days of the week, often clashing with earnings announcements and other big market events. It just doesn’t have the same place in the firmament.\nBut this month, for the first time in ages, inflation numbers are coming out on a Friday. And in another change to the established order, they matter a lot more than the unemployment numbers. Inflation is back, and nobody knows how long it’s going to stay. There is also the chance of a big round number, as some estimates put the headline rate of inflation above 7%. That’s unheard of since 1984.\nThe consensus estimate is a tad lower, but it’s a fair bet that the initial reaction will be binary, just as the first response on unemployment data day is usually driven by whether the change in non-farm payrolls is above or below expectations. If it’s above 7%, there will be an instant risk-off move, while anything below it will probably spark relief.\nBut that’s only for the very short term. After the first seconds of seeing the headline number, we’ll all have an immense amount of data to digest, which can be sliced and diced more or less any way you like. The numbers, coming ahead of a raft of central bank meetings next week, could have profound effects. This month, CPI Friday really should be a much bigger deal than NFP Friday.\nHere are a few points to help get ready:\nThe Labor Market Gives No Reason for Emergency Measures\nInflation is so important for gauging central banks’ reaction because there is now literally no reason at all to maintain emergency monetary measures for the sake of the labor market. This week’s figures on initial claims for unemployment insurance in the U.S. showed the fewest people signing on in more than 50 years. Adding in continued claims, the numbers on unemployment insurance are almost down to their level immediately before the pandemic. You have to go back to 1973 for the last time claims were lower than that:\n\nMeanwhile, data on job openings, known as JOLTS, show more vacancies than at any time since the survey started 20 years ago. Companies seem to be having little success filling them, implying much greater negotiating strength for workers in wage bargaining:\n\nOn that subject, the Atlanta Fed’s Wage Growth Tracker, based on census data, shows the fastest overall wage growth since 2007. But it’s lower than core consumer price inflation, so workers have an incentive to push for more:\n\nMeanwhile, the details from the wage tracker report suggest that historic changes are afoot in the labor market, with the youngest and lowest paid finally having the leverage to secure higher “compensation” while the best paidand over-55s are getting a worse deal than usual.\n\nIn short, the labor market suggests that the Fed should be reducing stimulus. Higher inflation would ram that home.\nFrom Now On, Base Effects Should Be Our Friends\nIf inflation does top 7%, remember that that figurereally could be transitory. The high headline numbers at present are driven partly by low base effects from 12 months ago, and the odds are heavily skewed toward those effects soon starting to turn positive. To cite the most important example, this is what has happened to year-on-year gasoline inflation over the last 16 years:\n\nGasoline prices are not going to keep increasing at more than 50% per annum. As the chart shows, the chances are that before long, they’ll be decreasing year-on-year and helping to lower headline inflation.\nLooking at commodity prices more generally, they tend to drive producer price inflation, for obvious reasons. And the broad-based Bloomberg Commodity Index has been declining of late:\n\nNone of this means that inflation will zoom back down to 2% in short order. But it does imply that the headline numbers are very likely to fall a bit before they rise. There’s currently little reason to expect sustained inflation of more than 7%.\nPeak Bottleneck Is Here, Perhaps\nAnother critical driver of this inflation spike has of course been the global interruption to supply chains. Bottlenecks have driven prices far higher by constricting supply. Restrictions to global transport remain extreme, but they seem to be peaking. In the following heat map, Moody’s Investors Service handily collated a number of measures of shipping rates. Most at least seem to have started to decline a little from the peak:\n\nConducting a similar exercise for global manufacturing and trade activity is also a little reassuring. U.S. manufacturers as a whole are in expansion mode, and railroad volumes are improving. However, semiconductor shipments have yet to show sustained improvement, and car production in the U.S. and Germany has been slowed as a result:\n\nThe semiconductor shortage made itself felt most in the motor industry at first, but as this chart from Gavekal Research shows, it appears to have moved on to smartphones. Smartphone sales are running slightly below their level a year ago:\n\nNone of this is reason to relax. There is still a serious supply chain problem across the world, and a new Covid variant might yet bring it back in full force. But it does look reasonable to say that this is about as bad as it will get, and that the worst might already be behind us. It’s certainly reasonable to expect that bottleneck resolution should be a downward pressure on inflation next year, just as they drove inflation upward in 2021.\nSo, a 7% inflation print would not be the end of the world, nor would it last forever. Bear that in mind at 8:30 a.m., New York time.\nExciting Times for Actuaries\nThe last two years have sent the actuarial profession rushing back in time. The industry had its birth in the Victorian era, to offer help dealing with the pressing risk that you might die too soon. Over the decades, medical progress helped make that risk easier and cheaper to protect against. But increasing longevity led to a new and even more difficult problem — the risk of living too long. For at least the last generation, actuaries have been preoccupied with the intractable task of guaranteeing a growing and aging population an income in retirement. The steady fall in bond yields has made this much harder by raising the price of buying a fixed income.\n2020 and 2021 have changed the pattern. The American Council of Life Insurers has published its annual survey of the total death benefit payments paid out by life insurers last year. The rise was the greatest in more than a century — although still far below the horrific increase in 1918, year of the Spanish Flu pandemic:\n\nThis does help confirm that the Covid pandemic did have real and tangible effect on public health, something that some people still doubt.\nIf the job of insuring lives grew a little harder, the job of assuring a pension grew easier. Rising share prices, making assets greater, combined with a rise in bond yields (making liabilities cheaper) to improve their funding position dramatically. Mercer, the actuarial group, published monthly estimates of the pension deficits of companies in the S&P 500 which offer defined benefit plans.\nThe numbers involved are huge.Mercer estimates that the aggregate value of pension plan assets of the S&P 1500 companies as of Oct. 31 was $2.32 trillion, compared with estimated aggregate liabilities of $2.44 trillion. Corporate pensions’ assets are now enough to cover 94% of their liabilities; an uncomfortable position, but a great relief after their funding status had dropped below 70% in the aftermath of the financial crisis:\n\nPension fund actuaries are also among the small but important group of people who would welcome higher bond yields. Amid difficult times, it’s encouraging that the looming pension crisis might yet resolve itself naturally.","news_type":1},"isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602111431,"gmtCreate":1638980262727,"gmtModify":1638980262877,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FTNT\">$Fortinet(FTNT)$</a>&nbsp;zscaler up 3%. Hello ftnt follow your industry and get lifted together&nbsp;","listText":"<a href=\"https://laohu8.com/S/FTNT\">$Fortinet(FTNT)$</a>&nbsp;zscaler up 3%. Hello ftnt follow your industry and get lifted together&nbsp;","text":"$Fortinet(FTNT)$ zscaler up 3%. Hello ftnt follow your industry and get lifted together","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602111431","isVote":1,"tweetType":1,"viewCount":997,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602139844,"gmtCreate":1638979161421,"gmtModify":1638979161658,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>&nbsp;tesla is now grandmother stock","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>&nbsp;tesla is now grandmother stock","text":"$Tesla Motors(TSLA)$ tesla is now grandmother stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/602139844","isVote":1,"tweetType":1,"viewCount":804,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602197256,"gmtCreate":1638979009722,"gmtModify":1638982255325,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FTNT\">$Fortinet(FTNT)$</a>&nbsp;zs up so much today. Follow your sector please :)&nbsp;","listText":"<a href=\"https://laohu8.com/S/FTNT\">$Fortinet(FTNT)$</a>&nbsp;zs up so much today. Follow your sector please :)&nbsp;","text":"$Fortinet(FTNT)$ zs up so much today. Follow your sector please :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602197256","isVote":1,"tweetType":1,"viewCount":718,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602192061,"gmtCreate":1638978638595,"gmtModify":1638978638802,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DIS\">$Walt Disney(DIS)$</a>spiderman no way home&nbsp;","listText":"<a href=\"https://laohu8.com/S/DIS\">$Walt Disney(DIS)$</a>spiderman no way home&nbsp;","text":"$Walt Disney(DIS)$spiderman no way home","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602192061","isVote":1,"tweetType":1,"viewCount":694,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602304838,"gmtCreate":1638967846540,"gmtModify":1638967846691,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"Any third party can verify their claims though?&nbsp;","listText":"Any third party can verify their claims though?&nbsp;","text":"Any third party can verify their claims though?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602304838","repostId":"1177589023","repostType":2,"repost":{"id":"1177589023","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638964838,"share":"https://www.laohu8.com/m/news/1177589023?lang=&edition=full","pubTime":"2021-12-08 20:00","market":"us","language":"en","title":"Pfizer, BioNTech say third dose neutralizes Omicron variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1177589023","media":"Tiger Newspress","summary":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on ","content":"<p>Pfizer and biontech stocks narrowed their losses&nbsp;in premarket trading&nbsp;after&nbsp;they provided update on Omicron variant.</p>\n<p><img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>\n <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>\n <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>\n <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li>\n</ul>\n<p>Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;today announced results from an initial&nbsp;<i>laboratory</i>&nbsp;study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p>\n<p>Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p>\n<p>A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p>\n<p>“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said&nbsp;<b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p>\n<p>“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said&nbsp;<b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p>\n<p>While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta &amp; Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech say third dose neutralizes Omicron variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech say third dose neutralizes Omicron variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer and biontech stocks narrowed their losses&nbsp;in premarket trading&nbsp;after&nbsp;they provided update on Omicron variant.</p>\n<p><img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>\n <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>\n <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>\n <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li>\n</ul>\n<p>Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;today announced results from an initial&nbsp;<i>laboratory</i>&nbsp;study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p>\n<p>Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p>\n<p>A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p>\n<p>“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said&nbsp;<b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p>\n<p>“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said&nbsp;<b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p>\n<p>While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta &amp; Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177589023","content_text":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.\n\n\nPreliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers\nData indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection\nAs 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease\nThe companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022\n\nPfizer Inc. and BioNTech SE today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.\nSera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.\nA more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.\n“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”\n“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”\nWhile these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.","news_type":1},"isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603153713,"gmtCreate":1638377461757,"gmtModify":1638377462083,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>&nbsp;8 days to cover? Will there be a short squeeze then? 🤔","listText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>&nbsp;8 days to cover? Will there be a short squeeze then? 🤔","text":"$Sea Ltd(SE)$ 8 days to cover? Will there be a short squeeze then? 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603153713","isVote":1,"tweetType":1,"viewCount":1046,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603186870,"gmtCreate":1638373780527,"gmtModify":1638374129015,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>the move down similar to FTNT &amp; ZS. Same industry meh?&nbsp;","listText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>the move down similar to FTNT &amp; ZS. Same industry meh?&nbsp;","text":"$Sea Ltd(SE)$the move down similar to FTNT & ZS. Same industry meh?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603186870","isVote":1,"tweetType":1,"viewCount":1142,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600775333,"gmtCreate":1638201897970,"gmtModify":1638201898243,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMAT\">$Applied Materials(AMAT)$</a>textbook breaking out of consolidation with retrace + bounce off resistance turned support&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMAT\">$Applied Materials(AMAT)$</a>textbook breaking out of consolidation with retrace + bounce off resistance turned support&nbsp;","text":"$Applied Materials(AMAT)$textbook breaking out of consolidation with retrace + bounce off resistance turned support","images":[{"img":"https://static.tigerbbs.com/0ed879a8767e693fce07fd9797196f12","width":"1080","height":"546"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600775333","isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":875947064,"gmtCreate":1637597147175,"gmtModify":1637597147261,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>is it going to hold?&nbsp;","listText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>is it going to hold?&nbsp;","text":"$Meta Platforms, Inc.(FB)$is it going to hold?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/875947064","isVote":1,"tweetType":1,"viewCount":790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875991236,"gmtCreate":1637593184252,"gmtModify":1637593184337,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RBLX\">$Roblox Corporation(RBLX)$</a>&nbsp;run!!&nbsp;","listText":"<a href=\"https://laohu8.com/S/RBLX\">$Roblox Corporation(RBLX)$</a>&nbsp;run!!&nbsp;","text":"$Roblox Corporation(RBLX)$ run!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875991236","isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875993245,"gmtCreate":1637593148100,"gmtModify":1637593148188,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>&nbsp;roblox and meta etf are diving","listText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>&nbsp;roblox and meta etf are diving","text":"$Meta Platforms, Inc.(FB)$ roblox and meta etf are diving","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875993245","isVote":1,"tweetType":1,"viewCount":296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875043344,"gmtCreate":1637591905579,"gmtModify":1637591905730,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>&nbsp;why are institutions selling? Take profit?&nbsp;","listText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>&nbsp;why are institutions selling? Take profit?&nbsp;","text":"$Meta Platforms, Inc.(FB)$ why are institutions selling? Take profit?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875043344","isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876237497,"gmtCreate":1637316689073,"gmtModify":1637316962647,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>&nbsp;at support level of channel, time to bounce!&nbsp;","listText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>&nbsp;at support level of channel, time to bounce!&nbsp;","text":"$Meta Platforms, Inc.(FB)$ at support level of channel, time to bounce!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876237497","isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876983815,"gmtCreate":1637249059818,"gmtModify":1637249059903,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>Keybanc analyst John Vinh maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Piper Sandler analyst Harsh Kumar maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Mizuho analyst Vijay Rakesh maintained Nvidia with a Buy rating and raised the price target from $235 to $335.Raymond James analyst Chris Caso maintained Nvidia with a Strong Buy rating and raised the price target from $225 to $365.Needham analyst Rajvindra Gill maintained Nvidia with a Buy rating and raised the price target from $245 to $400.Truist Securities analyst William Stein maintained Nvidia with a Buy rating and raised the price target from $360 to $389.","listText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>Keybanc analyst John Vinh maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Piper Sandler analyst Harsh Kumar maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Mizuho analyst Vijay Rakesh maintained Nvidia with a Buy rating and raised the price target from $235 to $335.Raymond James analyst Chris Caso maintained Nvidia with a Strong Buy rating and raised the price target from $225 to $365.Needham analyst Rajvindra Gill maintained Nvidia with a Buy rating and raised the price target from $245 to $400.Truist Securities analyst William Stein maintained Nvidia with a Buy rating and raised the price target from $360 to $389.","text":"$NVIDIA Corp(NVDA)$Keybanc analyst John Vinh maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Piper Sandler analyst Harsh Kumar maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Mizuho analyst Vijay Rakesh maintained Nvidia with a Buy rating and raised the price target from $235 to $335.Raymond James analyst Chris Caso maintained Nvidia with a Strong Buy rating and raised the price target from $225 to $365.Needham analyst Rajvindra Gill maintained Nvidia with a Buy rating and raised the price target from $245 to $400.Truist Securities analyst William Stein maintained Nvidia with a Buy rating and raised the price target from $360 to $389.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876983815","isVote":1,"tweetType":1,"viewCount":779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876939131,"gmtCreate":1637248038043,"gmtModify":1637248038163,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>&nbsp;330 tonight","listText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>&nbsp;330 tonight","text":"$NVIDIA Corp(NVDA)$ 330 tonight","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876939131","isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878160372,"gmtCreate":1637160118640,"gmtModify":1637160118726,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>test 350 tonight?","listText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>test 350 tonight?","text":"$Meta Platforms, Inc.(FB)$test 350 tonight?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878160372","isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873748926,"gmtCreate":1636989273972,"gmtModify":1636989274100,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FTNT\">$Fortinet(FTNT)$</a>many stop losses are likely filled time for the v shape rebound","listText":"<a href=\"https://laohu8.com/S/FTNT\">$Fortinet(FTNT)$</a>many stop losses are likely filled time for the v shape rebound","text":"$Fortinet(FTNT)$many stop losses are likely filled time for the v shape rebound","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873748926","isVote":1,"tweetType":1,"viewCount":491,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873701190,"gmtCreate":1636983629623,"gmtModify":1636983629745,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579088083036701","authorIdStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>time to complete inverse h&amp;s tonight. Spring up let's go!&nbsp;","listText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>time to complete inverse h&amp;s tonight. Spring up let's go!&nbsp;","text":"$Meta Platforms, Inc.(FB)$time to complete inverse h&s tonight. Spring up let's go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873701190","isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":812564166,"gmtCreate":1630595353555,"gmtModify":1631886289288,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>feels like shortists are shorting v to oblivion, not because anything is wrong with visa...","listText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>feels like shortists are shorting v to oblivion, not because anything is wrong with visa...","text":"$Visa(V)$feels like shortists are shorting v to oblivion, not because anything is wrong with visa...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/812564166","isVote":1,"tweetType":1,"viewCount":1300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897035380,"gmtCreate":1628862420040,"gmtModify":1631884142349,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>&nbsp;too many sellers&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>&nbsp;too many sellers&nbsp;","text":"$Moderna, Inc.(MRNA)$ too many sellers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/897035380","isVote":1,"tweetType":1,"viewCount":895,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899327953,"gmtCreate":1628162594572,"gmtModify":1631893495610,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>probably the last chance to buy now for those who wanna join the ride&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>probably the last chance to buy now for those who wanna join the ride&nbsp;","text":"$Moderna, Inc.(MRNA)$probably the last chance to buy now for those who wanna join the ride","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/899327953","isVote":1,"tweetType":1,"viewCount":896,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885547780,"gmtCreate":1631805918140,"gmtModify":1631891608882,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"I will just buy both when they are going at discount&nbsp;","listText":"I will just buy both when they are going at discount&nbsp;","text":"I will just buy both when they are going at discount","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/885547780","repostId":"1126607843","repostType":4,"repost":{"id":"1126607843","pubTimestamp":1631785252,"share":"https://www.laohu8.com/m/news/1126607843?lang=&edition=full","pubTime":"2021-09-16 17:40","market":"us","language":"en","title":"Apple Vs. Microsoft: Who Is Inclined To Fall Harder In Case Of Correction","url":"https://stock-news.laohu8.com/highlight/detail?id=1126607843","media":"seekingalpha","summary":"Summary\n\nObjectively, the likelihood of a significant correction in the stock market now deserves at","content":"<p><b>Summary</b></p>\n<ul>\n <li>Objectively, the likelihood of a significant correction in the stock market now deserves attention.</li>\n <li>In the recent past, Apple and Microsoft have responded differently to a significant decline in the stock market.</li>\n <li>Apple and&nbsp;Microsoft tend to be undervalued in terms of future cash flow, and overvalued in terms of potential dividends.</li>\n <li>In the event of a hypothetical correction, Microsoft's potential for falling is lower than Apple's.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a07b4e98bb726c0044932fc29b3089b3\" tg-width=\"1536\" tg-height=\"1208\" width=\"100%\" height=\"auto\"><span>vicnt/iStock via Getty Images</span></p>\n<p><b>As an introduction...</b></p>\n<p>Since the last major correction in the US stock market ended in March 2020, the Nasdaq index has risen nearly 170%:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/05a849f8e9ddf15f484770a5f0227fcd\" tg-width=\"635\" tg-height=\"371\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>For a year and a half, this is a very strong result, considering that the average annual total price return of the index over the past decade does not exceed 20%.<i>This fact alone makes us estimate the likelihood of a new significant correction in the stock market higher.</i></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/37eb0178d9d463c7419b99632a6ec614\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"><span>Source: VisualizedAnalytics</span></p>\n<p>In addition, there are other factors that make us wary of the current price level of the market.</p>\n<p>First, this year there is a record inflow of liquidity to the stock market. I'm not talking about the reasons now, they are obvious. But this fact alone makes the market extremely volatile:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/10623d7cecd8dec70bb229b809458b68\" tg-width=\"1242\" tg-height=\"918\" width=\"100%\" height=\"auto\"><span>Source: Bank of America</span></p>\n<p>Second, the relative size of the US stock market has exceeded 200% of nominal GDP. In principle, this is not a fundamental limit. But it was the ultra-soft monetary policy that allowed the US stock market to reach its current record level. And most likely, in this context, a reversal is&nbsp;already outlined.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f69cd6450737ddf3e5fcbd6406c793ba\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"><span>Source: VisualizedAnalytics</span></p>\n<p>And finally the third. The macrocycle also allows us to expect the market to enter a phase of increased volatility and tightening of monetary policy:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d6a6a794dde6f4e1d3e6e9149b55060\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"><span>Source: VisualizedAnalytics</span></p>\n<p>So, objectively, the likelihood of the next correction of the stock market at least deserves attention. And in this context, I propose to answer the question:<i>in case of a correction, which company is inclined to fall harder - Apple (AAPL) or Microsoft (MSFT)?</i></p>\n<p><b>Why Apple vs. Microsoft?</b></p>\n<p>The decision to compare exactly these two companies was dictated by two factors.</p>\n<p>Firstly, these are the two largest companies in the tech sector, together accounting for more than 10% of the total capitalization of the US stock market. These companies are so large that, in principle, their dynamics alone can cause a new wave of correction:</p>\n<p><img src=\"https://static.tigerbbs.com/cf3ef401b67c298ecbd9d56d31fc6927\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/31417d34d6eacb724c20b3a274068467\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"><span>Source: VisualizedAnalytics</span></p>\n<p>Secondly, both companies pay dividends. In matters of fundamental valuation, this factor plays a significant role.</p>\n<p><b>Some Statistics</b></p>\n<p>To begin with, let's take a look at what price dynamics both companies have shown during strong market fluctuations in the recent past.</p>\n<p>To do this, I have broken the three-year span into eight periods of market movement:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/edfd9dec91d94990cf5217aa649758ac\" tg-width=\"947\" tg-height=\"578\" width=\"100%\" height=\"auto\"><span>Source: TradingView, Author</span></p>\n<p>Here are the results that companies have shown in each of the periods:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/868067f19c2251bfdb0658a251596fcc\" tg-width=\"640\" tg-height=\"214\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p>\n<p>At first glance, the statistics are unambiguous:<i>during periods of correction, the price of Microsoft tends to decrease less than that of Apple.</i>But on the other hand, Apple has consistently performed better during periods of market growth. And in this case, the result obtained can simply be explained by the technical factors of the market behavior.</p>\n<p>But in the current period of growth, both companies demonstrate approximately the same return. And therefore, here we do not find a clue to our question...</p>\n<p><b>Fundamentals</b></p>\n<p>Exclusively in an investment context, the price of a company's share can be viewed from two points of view.</p>\n<p>On the one hand, the price reflects the present value of the company's&nbsp;<b>future cash flow</b>. On the other hand, the price is the present value of the sum of&nbsp;<b>all potential dividends</b>that the company will pay in the future. Let's model these prices for Apple and Microsoft. And for this I will build, respectively, the Discounted Cash Flow Model and the Dividend Discount Model.</p>\n<p>In order for the models to be less subjective, I will take as a basis the average expectations of analysts regarding the revenue and EPS of the companies in the next decade.</p>\n<p>Let's start with&nbsp;<b>Apple</b>. Here is the calculation of the Weighted Average Cost of Capital:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f8fc4e5dc7025dd1227ea5279073aa5\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p>\n<p>Notes:</p>\n<ul>\n <li>In order to calculate the market rate of return, I used values of equityriskpremium (4.72%) and the current yield of UST10 as a risk-free rate (1.33%).</li>\n <li>I used the current&nbsp;value&nbsp;of the three-year beta coefficient. For a terminal year, I used Beta equal to 1.</li>\n <li>To calculate the Cost of Debt, I used the interest expense for 2020 divided by the average debt in 2019 and 2018.</li>\n</ul>\n<p>Here is the DCF model:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9bfb45a9125bb1f465cd34a6a8a6d06a\" tg-width=\"640\" tg-height=\"520\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p>\n<p><b>The DCF-based target price for Apple's shares is about $181 (+22%).</b></p>\n<p>In the case of Apple, when building the Dividend Discount Model it is also necessary to take into account the fact that the company continues to actively buy back:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d84076d0fc1bb5dbec8c1e6e19434153\" tg-width=\"635\" tg-height=\"371\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>Continuing the current dynamics, the model assumes that by the terminal year the number of diluted shares will be reduced to 13.5 billion.</p>\n<p>Apple spends an average of 25% of its net income on dividends. I assume that the payout ratio will remain at this level.</p>\n<p>Here is the Dividend Discount Model itself:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b8990a8299cc0652d77815710f0ab427\" tg-width=\"640\" tg-height=\"292\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p>\n<p><b><i>The DDM-based target price for Apple's shares is $69 (-54%).</i></b></p>\n<p>Now let's take a look at Microsoft.</p>\n<p>Here is the calculation of the WACC:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/15889e90904c69497b749f28bd64190f\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p>\n<p>And here is the DCF model:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7dca7339e43f534807bf043b1931e1db\" tg-width=\"640\" tg-height=\"506\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p>\n<p><b>The DCF-based target price for Microsoft's shares is about $353 (+18%).</b></p>\n<p>Microsoft is also actively buying back shares:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1deec463f584b5eb7913d72938d3e1ca\" tg-width=\"635\" tg-height=\"371\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>I proceed from the assumption that the dynamics of the last two years will continue, and by the terminal year, the number of diluted shares will be reduced to 7.2 billion.</p>\n<p>Here is the Dividend Discount Model:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/18c863b92e948f78e518d5619b44647d\" tg-width=\"640\" tg-height=\"283\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p>\n<p><b><i>The DDM-based target price for Microsoft's shares is $203 (-32%).</i></b></p>\n<p>Let's summarize:</p>\n<p><img src=\"https://static.tigerbbs.com/84b527d82270843e021a89a9ecdf68e6\" tg-width=\"906\" tg-height=\"212\" width=\"100%\" height=\"auto\"></p>\n<p>It is worth noting that I have already been observing similar results in the case of these companies for a long time. I mean, Apple and Microsoft tend to be undervalued in terms of future cash flow, and overvalued in terms of potential dividends.</p>\n<p>This suggests that during periods of market growth, investors are not particularly inclined to pay attention to dividends. Moreover, most likely dividends are perceived simply as a bonus.</p>\n<p>But during periods of market correction, the present value of potential dividends is the minimum level below which it is difficult for the price to fall. And in this context, I think Microsoft is in a better position than Apple.</p>\n<p><b>Bottom line</b></p>\n<p>At the current stage of the market cycle, when the likelihood of a correction has gone beyond formal, in my opinion, investing in Microsoft is less risky compared to Apple.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Vs. Microsoft: Who Is Inclined To Fall Harder In Case Of Correction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Vs. Microsoft: Who Is Inclined To Fall Harder In Case Of Correction\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-16 17:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4455478-apple-stock-vs-microsoft-stock-who-is-inclined-to-fall-harder-in-case-of-correction><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nObjectively, the likelihood of a significant correction in the stock market now deserves attention.\nIn the recent past, Apple and Microsoft have responded differently to a significant decline...</p>\n\n<a href=\"https://seekingalpha.com/article/4455478-apple-stock-vs-microsoft-stock-who-is-inclined-to-fall-harder-in-case-of-correction\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/article/4455478-apple-stock-vs-microsoft-stock-who-is-inclined-to-fall-harder-in-case-of-correction","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126607843","content_text":"Summary\n\nObjectively, the likelihood of a significant correction in the stock market now deserves attention.\nIn the recent past, Apple and Microsoft have responded differently to a significant decline in the stock market.\nApple and Microsoft tend to be undervalued in terms of future cash flow, and overvalued in terms of potential dividends.\nIn the event of a hypothetical correction, Microsoft's potential for falling is lower than Apple's.\n\nvicnt/iStock via Getty Images\nAs an introduction...\nSince the last major correction in the US stock market ended in March 2020, the Nasdaq index has risen nearly 170%:\nData by YCharts\nFor a year and a half, this is a very strong result, considering that the average annual total price return of the index over the past decade does not exceed 20%.This fact alone makes us estimate the likelihood of a new significant correction in the stock market higher.\nSource: VisualizedAnalytics\nIn addition, there are other factors that make us wary of the current price level of the market.\nFirst, this year there is a record inflow of liquidity to the stock market. I'm not talking about the reasons now, they are obvious. But this fact alone makes the market extremely volatile:\nSource: Bank of America\nSecond, the relative size of the US stock market has exceeded 200% of nominal GDP. In principle, this is not a fundamental limit. But it was the ultra-soft monetary policy that allowed the US stock market to reach its current record level. And most likely, in this context, a reversal is already outlined.\nSource: VisualizedAnalytics\nAnd finally the third. The macrocycle also allows us to expect the market to enter a phase of increased volatility and tightening of monetary policy:\nSource: VisualizedAnalytics\nSo, objectively, the likelihood of the next correction of the stock market at least deserves attention. And in this context, I propose to answer the question:in case of a correction, which company is inclined to fall harder - Apple (AAPL) or Microsoft (MSFT)?\nWhy Apple vs. Microsoft?\nThe decision to compare exactly these two companies was dictated by two factors.\nFirstly, these are the two largest companies in the tech sector, together accounting for more than 10% of the total capitalization of the US stock market. These companies are so large that, in principle, their dynamics alone can cause a new wave of correction:\n\nSource: VisualizedAnalytics\nSecondly, both companies pay dividends. In matters of fundamental valuation, this factor plays a significant role.\nSome Statistics\nTo begin with, let's take a look at what price dynamics both companies have shown during strong market fluctuations in the recent past.\nTo do this, I have broken the three-year span into eight periods of market movement:\nSource: TradingView, Author\nHere are the results that companies have shown in each of the periods:\nSource: Author\nAt first glance, the statistics are unambiguous:during periods of correction, the price of Microsoft tends to decrease less than that of Apple.But on the other hand, Apple has consistently performed better during periods of market growth. And in this case, the result obtained can simply be explained by the technical factors of the market behavior.\nBut in the current period of growth, both companies demonstrate approximately the same return. And therefore, here we do not find a clue to our question...\nFundamentals\nExclusively in an investment context, the price of a company's share can be viewed from two points of view.\nOn the one hand, the price reflects the present value of the company's future cash flow. On the other hand, the price is the present value of the sum of all potential dividendsthat the company will pay in the future. Let's model these prices for Apple and Microsoft. And for this I will build, respectively, the Discounted Cash Flow Model and the Dividend Discount Model.\nIn order for the models to be less subjective, I will take as a basis the average expectations of analysts regarding the revenue and EPS of the companies in the next decade.\nLet's start with Apple. Here is the calculation of the Weighted Average Cost of Capital:\nSource: Author\nNotes:\n\nIn order to calculate the market rate of return, I used values of equityriskpremium (4.72%) and the current yield of UST10 as a risk-free rate (1.33%).\nI used the current value of the three-year beta coefficient. For a terminal year, I used Beta equal to 1.\nTo calculate the Cost of Debt, I used the interest expense for 2020 divided by the average debt in 2019 and 2018.\n\nHere is the DCF model:\nSource: Author\nThe DCF-based target price for Apple's shares is about $181 (+22%).\nIn the case of Apple, when building the Dividend Discount Model it is also necessary to take into account the fact that the company continues to actively buy back:\nData by YCharts\nContinuing the current dynamics, the model assumes that by the terminal year the number of diluted shares will be reduced to 13.5 billion.\nApple spends an average of 25% of its net income on dividends. I assume that the payout ratio will remain at this level.\nHere is the Dividend Discount Model itself:\nSource: Author\nThe DDM-based target price for Apple's shares is $69 (-54%).\nNow let's take a look at Microsoft.\nHere is the calculation of the WACC:\nSource: Author\nAnd here is the DCF model:\nSource: Author\nThe DCF-based target price for Microsoft's shares is about $353 (+18%).\nMicrosoft is also actively buying back shares:\nData by YCharts\nI proceed from the assumption that the dynamics of the last two years will continue, and by the terminal year, the number of diluted shares will be reduced to 7.2 billion.\nHere is the Dividend Discount Model:\nSource: Author\nThe DDM-based target price for Microsoft's shares is $203 (-32%).\nLet's summarize:\n\nIt is worth noting that I have already been observing similar results in the case of these companies for a long time. I mean, Apple and Microsoft tend to be undervalued in terms of future cash flow, and overvalued in terms of potential dividends.\nThis suggests that during periods of market growth, investors are not particularly inclined to pay attention to dividends. Moreover, most likely dividends are perceived simply as a bonus.\nBut during periods of market correction, the present value of potential dividends is the minimum level below which it is difficult for the price to fall. And in this context, I think Microsoft is in a better position than Apple.\nBottom line\nAt the current stage of the market cycle, when the likelihood of a correction has gone beyond formal, in my opinion, investing in Microsoft is less risky compared to Apple.","news_type":1},"isVote":1,"tweetType":1,"viewCount":35,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811189156,"gmtCreate":1630297138075,"gmtModify":1704958017528,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"Just don't crash the market and everyone be happy&nbsp;","listText":"Just don't crash the market and everyone be happy&nbsp;","text":"Just don't crash the market and everyone be happy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/811189156","repostId":"1198438768","repostType":4,"repost":{"id":"1198438768","pubTimestamp":1630284738,"share":"https://www.laohu8.com/m/news/1198438768?lang=&edition=full","pubTime":"2021-08-30 08:52","market":"us","language":"en","title":"Fed’s Powell Cheers Markets But Risks a Mistake","url":"https://stock-news.laohu8.com/highlight/detail?id=1198438768","media":"Bloomberg","summary":"Investors will happily continue to give the Federal Reserve chair the benefit of the doubt, but ther","content":"<blockquote>\n Investors will happily continue to give the Federal Reserve chair&nbsp;the benefit of the doubt, but there’s good reason to question his characterization of policy being “well positioned.”\n</blockquote>\n<p>Federal Reserve Chair Jerome Powell’s speech Friday at the annual Jackson Hole forum was consistent with his very gradual and highly measured approach to policy changes – an approach that financial markets love as it implies a longer period of very loose liquidity that fuels ever higher asset prices. The real question, however, is whether the speech will end up being out of touch with actual economic and financial developments as they unfold over the remainder of this year and beyond.</p>\n<p>By refraining from breaking new ground or providing operational details of any evolution in policy, both of which would have inevitably tilted more hawkish at this point, Powell gave investors more reason to take stocks and bonds higher. And indeed, stocks rallied to a new record while bond prices also rose.</p>\n<p>Economists, however, seemed less convinced by the argumentation, the stated outlook and what it implies for the Fed’s go-slow policy evolution that markets like so much. More concerned about the two-sided nature of the inflation risk and the potential for a policy mistake, some would have favored a firmer signal about an imminent taper of the Fed’s large-scale asset purchases, something that I have argued is not just needed for both economic wellbeing and longer-term financial stability, but is also overdue.</p>\n<p>Powell in his speech appeared mindful not only of the latest facts on the ground that could guide Fed action, but also of the highly visible and accelerating hawkish swing among a growing number of members the policy-making Federal Open Market Committee. Specifically, in evaluating recent economic developments against the Fed’s formal dual mandate (price stability and employment), he observed thatthe Fed’s \"substantial further progress\" test of the economic recovery has been met as regards inflation, and that “there has also been clear progress toward maximum employment.”</p>\n<p>As these remarks&nbsp;would imply him being inclined toward an earlier taper timetable than he favored just a few weeks ago, Powell was quick to wrap this economic assessment in a twin packaging that was more dovish than what markets expected.</p>\n<p>First, Powell made a point of separating the move toward tapering from interest rate hikes that would normally follow. He stated that “the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff, for which we have articulated a different and substantially more stringent test.”</p>\n<p>Second, in addition to refraining from providing details on the timing and pace a possible taper program, he built into such a future announcement quite a bit of what I suspect he hopes is constructive ambiguity. This included him stating that “we have much ground to cover to reach maximum employment, and time will tell whether we have reached 2 percent inflation on a sustainable basis.”</p>\n<p>This messaging is clearly meant to avoid the market disruptions that followed the first taper announcement in 2013 under then-Fed Chairman Ben Bernanke and Powell’s own experience in the fourth quarter of 2018. However, there’s good reason to question the characterization of Fed policy being “well positioned.” For example:</p>\n<ul>\n <li>The five reasons that Powell set out to support his oft-repeated argument that the recent spike in prices is likely transitory do little to alleviate current concerns about an inflation dynamic that is already proven and, judging from Friday’s data, continues to be hotter and more persistent than the Fed expects.</li>\n <li>His failure to mention housing and rental inflationmissed an important partof the evolving inflation story, and one that has consequential economic, social and political implications.</li>\n <li>Powell’s outlook for the economy doesn’t seem to reflect sufficient appreciation of the bottom-up, cost-push pressures that the majority of companies are experiencing and that several regional Fed presidents have cited in their own assessments of the economic outlook and their associated call for an early taper.</li>\n <li>After a balanced historical reading of policy reactions to higher inflation, Powell’s characterization of the current risk of a potential policy mistake appears overly biased in favor of an overreaction to inflation. If anything, the Fed is quite far from this given that it is still maintaining the uber-stimulative policy stance that it adopted well over a year ago at the height of the Covid disruptions to the economy and markets.</li>\n <li>Finally, while rightly pointing to the uncertainties associated with the delta variant, Powell shied away from discussing the considerable and increasing decoupling of finance from the real economy.</li>\n</ul>\n<p>Investors will happily continue to give Powell the benefit of the doubt;after all, his policy approach has paved the way for increasing financial wealth. Economists, though, are more divided. The beneficial impact on the economy of the Fed’s massive asset purchases are limited, if any, while the risks to economy and the financial system continue to mount.</p>\n<p>I continue to believe there is just cause for concern about a monetary policy mistake that could undermine future economic wellbeing and financial stability, with adverse social, institutional and political spillovers.I am hoping that my worries are misplaced but unfortunately, both the numbers and the analysis suggest otherwise.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed’s Powell Cheers Markets But Risks a Mistake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed’s Powell Cheers Markets But Risks a Mistake\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-30 08:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/opinion/articles/2021-08-29/federal-reserve-chair-jerome-powell-s-dovish-tilt-risks-a-mistake><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors will happily continue to give the Federal Reserve chair the benefit of the doubt, but there’s good reason to question his characterization of policy being “well positioned.”\n\nFederal Reserve...</p>\n\n<a href=\"https://www.bloomberg.com/opinion/articles/2021-08-29/federal-reserve-chair-jerome-powell-s-dovish-tilt-risks-a-mistake\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.bloomberg.com/opinion/articles/2021-08-29/federal-reserve-chair-jerome-powell-s-dovish-tilt-risks-a-mistake","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198438768","content_text":"Investors will happily continue to give the Federal Reserve chair the benefit of the doubt, but there’s good reason to question his characterization of policy being “well positioned.”\n\nFederal Reserve Chair Jerome Powell’s speech Friday at the annual Jackson Hole forum was consistent with his very gradual and highly measured approach to policy changes – an approach that financial markets love as it implies a longer period of very loose liquidity that fuels ever higher asset prices. The real question, however, is whether the speech will end up being out of touch with actual economic and financial developments as they unfold over the remainder of this year and beyond.\nBy refraining from breaking new ground or providing operational details of any evolution in policy, both of which would have inevitably tilted more hawkish at this point, Powell gave investors more reason to take stocks and bonds higher. And indeed, stocks rallied to a new record while bond prices also rose.\nEconomists, however, seemed less convinced by the argumentation, the stated outlook and what it implies for the Fed’s go-slow policy evolution that markets like so much. More concerned about the two-sided nature of the inflation risk and the potential for a policy mistake, some would have favored a firmer signal about an imminent taper of the Fed’s large-scale asset purchases, something that I have argued is not just needed for both economic wellbeing and longer-term financial stability, but is also overdue.\nPowell in his speech appeared mindful not only of the latest facts on the ground that could guide Fed action, but also of the highly visible and accelerating hawkish swing among a growing number of members the policy-making Federal Open Market Committee. Specifically, in evaluating recent economic developments against the Fed’s formal dual mandate (price stability and employment), he observed thatthe Fed’s \"substantial further progress\" test of the economic recovery has been met as regards inflation, and that “there has also been clear progress toward maximum employment.”\nAs these remarks would imply him being inclined toward an earlier taper timetable than he favored just a few weeks ago, Powell was quick to wrap this economic assessment in a twin packaging that was more dovish than what markets expected.\nFirst, Powell made a point of separating the move toward tapering from interest rate hikes that would normally follow. He stated that “the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff, for which we have articulated a different and substantially more stringent test.”\nSecond, in addition to refraining from providing details on the timing and pace a possible taper program, he built into such a future announcement quite a bit of what I suspect he hopes is constructive ambiguity. This included him stating that “we have much ground to cover to reach maximum employment, and time will tell whether we have reached 2 percent inflation on a sustainable basis.”\nThis messaging is clearly meant to avoid the market disruptions that followed the first taper announcement in 2013 under then-Fed Chairman Ben Bernanke and Powell’s own experience in the fourth quarter of 2018. However, there’s good reason to question the characterization of Fed policy being “well positioned.” For example:\n\nThe five reasons that Powell set out to support his oft-repeated argument that the recent spike in prices is likely transitory do little to alleviate current concerns about an inflation dynamic that is already proven and, judging from Friday’s data, continues to be hotter and more persistent than the Fed expects.\nHis failure to mention housing and rental inflationmissed an important partof the evolving inflation story, and one that has consequential economic, social and political implications.\nPowell’s outlook for the economy doesn’t seem to reflect sufficient appreciation of the bottom-up, cost-push pressures that the majority of companies are experiencing and that several regional Fed presidents have cited in their own assessments of the economic outlook and their associated call for an early taper.\nAfter a balanced historical reading of policy reactions to higher inflation, Powell’s characterization of the current risk of a potential policy mistake appears overly biased in favor of an overreaction to inflation. If anything, the Fed is quite far from this given that it is still maintaining the uber-stimulative policy stance that it adopted well over a year ago at the height of the Covid disruptions to the economy and markets.\nFinally, while rightly pointing to the uncertainties associated with the delta variant, Powell shied away from discussing the considerable and increasing decoupling of finance from the real economy.\n\nInvestors will happily continue to give Powell the benefit of the doubt;after all, his policy approach has paved the way for increasing financial wealth. Economists, though, are more divided. The beneficial impact on the economy of the Fed’s massive asset purchases are limited, if any, while the risks to economy and the financial system continue to mount.\nI continue to believe there is just cause for concern about a monetary policy mistake that could undermine future economic wellbeing and financial stability, with adverse social, institutional and political spillovers.I am hoping that my worries are misplaced but unfortunately, both the numbers and the analysis suggest otherwise.","news_type":1},"isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":602304838,"gmtCreate":1638967846540,"gmtModify":1638967846691,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"Any third party can verify their claims though?&nbsp;","listText":"Any third party can verify their claims though?&nbsp;","text":"Any third party can verify their claims though?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602304838","repostId":"1177589023","repostType":2,"repost":{"id":"1177589023","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638964838,"share":"https://www.laohu8.com/m/news/1177589023?lang=&edition=full","pubTime":"2021-12-08 20:00","market":"us","language":"en","title":"Pfizer, BioNTech say third dose neutralizes Omicron variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1177589023","media":"Tiger Newspress","summary":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on ","content":"<p>Pfizer and biontech stocks narrowed their losses&nbsp;in premarket trading&nbsp;after&nbsp;they provided update on Omicron variant.</p>\n<p><img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>\n <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>\n <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>\n <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li>\n</ul>\n<p>Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;today announced results from an initial&nbsp;<i>laboratory</i>&nbsp;study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p>\n<p>Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p>\n<p>A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p>\n<p>“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said&nbsp;<b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p>\n<p>“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said&nbsp;<b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p>\n<p>While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta &amp; Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech say third dose neutralizes Omicron variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech say third dose neutralizes Omicron variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer and biontech stocks narrowed their losses&nbsp;in premarket trading&nbsp;after&nbsp;they provided update on Omicron variant.</p>\n<p><img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>\n <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>\n <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>\n <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li>\n</ul>\n<p>Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;today announced results from an initial&nbsp;<i>laboratory</i>&nbsp;study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p>\n<p>Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p>\n<p>A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p>\n<p>“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said&nbsp;<b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p>\n<p>“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said&nbsp;<b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p>\n<p>While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta &amp; Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177589023","content_text":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.\n\n\nPreliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers\nData indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection\nAs 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease\nThe companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022\n\nPfizer Inc. and BioNTech SE today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.\nSera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.\nA more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.\n“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”\n“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”\nWhile these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.","news_type":1},"isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856969353,"gmtCreate":1635142363945,"gmtModify":1635142448576,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"Facebook is a leader. Snap isn't. Why let snap lead Facebook into earnings?&nbsp;","listText":"Facebook is a leader. Snap isn't. Why let snap lead Facebook into earnings?&nbsp;","text":"Facebook is a leader. Snap isn't. Why let snap lead Facebook into earnings?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856969353","repostId":"1167039476","repostType":4,"repost":{"id":"1167039476","pubTimestamp":1635123100,"share":"https://www.laohu8.com/m/news/1167039476?lang=&edition=full","pubTime":"2021-10-25 08:51","market":"us","language":"en","title":"Facebook Reports Earnings Monday. Snap Earnings Weren’t a Great Sign.","url":"https://stock-news.laohu8.com/highlight/detail?id=1167039476","media":"Barrons","summary":"After Snap said it took a revenue hit from Apple’s recent privacy changes for mobile advertising, in","content":"<p>After&nbsp;Snap&nbsp;said it took a revenue hit from&nbsp;Apple’s&nbsp;recent privacy changes for mobile advertising, investors wondered what it could mean for&nbsp;Facebook.They won’t have to wait long for an answer.</p>\n<p>Facebook (ticker: FB) is set to report third quarter earnings results after the market closes on Monday, but news from Snap (SNAP) sent Facebook shares down 5.1% in Friday trading after results for Snapchat’s parent company fell short of expectations. A key concern among investors was the impact of Apple’s changes to targeted advertising on mobile devices: Applenow asks users if they want to opt in to the practice, and data from research firm Flurry&nbsp;suggests only 15% of U.S. consumers opt into tracking when offered the choice. Facebook’s report on Monday will show how widespread the impact is to mobile advertising-focused firms.</p>\n<p>Wall Street’s consensus estimate for Facebook’s third quarter calls for sales of $29.57 billion and earnings of $3.19 a share, according to FactSet. Analysts forecast that monthly active users hit 2.92 billion during the quarter, and predict that Facebook had 1.93 billion daily active users.</p>\n<p>“We expect Q3 results/outlook probably a bit better than Snap’s, with the company already acknowledging targeting headwinds, and more proactively developing tools to help with measurement and attribution,” Baird analyst Colin Sebastian wrote on Monday.</p>\n<p>There’s a lot more news swirling around Facebook, with the company mulling changing its name, The Verge reports. (<i>Barron’s</i> was unable to corroborate The Verge’s report, which cites one anonymous source.) Earlier this month, whistleblower Frances Haugen’s damaging testimony about internal data and documents she submitted to lawmakers, regulators, and journalists seemed to drum up more support in Washington, D.C. for reining in the company. What steps, if any, lawmakers will take is unclear.</p>\n<p>In a statement posted on Twitter, Facebook’s policy communications director Andy Stone said the company does not agree with many of Haugen’s characterizations of the issues she testified about, but called on lawmakers to make a standard set of rules for the internet.</p>\n<p>Investors might wonder if a potential name change for Facebook is linked to a string of controversies in recent years about user data and its app’s potential influence on political polarization.On the flip side, the company is much more than its social network bearing the same name: It also owns Instagram, WhatsApp, and virtual reality headset maker Oculus.</p>\n<p>Beyond the company’s Monday earnings call, investors will be able to hear from Facebook CEO Mark Zuckerberg on Oct. 28, when he is slated to speak during the company’s virtual Facebook Connect event.Zuckerberg is set to discuss Facebook’s interest in the metaverse, a theorized next evolution of the internet, in which users socialize, shop, and consume entertainment in always-online virtual worlds.</p>\n<p>The metaverse has been on Facebook’s radar for some time: The company bought Oculus in 2014, and during the company’s July conference call, Zuckerberg said building the metaverse was the company’s long-term aspiration. But Facebook isn’t the only company trying to build the metaverse, with upstarts in the videogame business like closely held Epic Games’ Fortnite,Roblox&nbsp;(RBLX), and&nbsp;Microsoft’s&nbsp;(MSFT) Minecraft all breaking ground on such online experiences.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Facebook Reports Earnings Monday. Snap Earnings Weren’t a Great Sign.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFacebook Reports Earnings Monday. Snap Earnings Weren’t a Great Sign.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-25 08:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/facebook-stock-earnings-preview-51635020234?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After Snap said it took a revenue hit from Apple’s recent privacy changes for mobile advertising, investors wondered what it could mean for Facebook.They won’t have to wait long for an answer.\n...</p>\n\n<a href=\"https://www.barrons.com/articles/facebook-stock-earnings-preview-51635020234?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/facebook-stock-earnings-preview-51635020234?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167039476","content_text":"After Snap said it took a revenue hit from Apple’s recent privacy changes for mobile advertising, investors wondered what it could mean for Facebook.They won’t have to wait long for an answer.\nFacebook (ticker: FB) is set to report third quarter earnings results after the market closes on Monday, but news from Snap (SNAP) sent Facebook shares down 5.1% in Friday trading after results for Snapchat’s parent company fell short of expectations. A key concern among investors was the impact of Apple’s changes to targeted advertising on mobile devices: Applenow asks users if they want to opt in to the practice, and data from research firm Flurry suggests only 15% of U.S. consumers opt into tracking when offered the choice. Facebook’s report on Monday will show how widespread the impact is to mobile advertising-focused firms.\nWall Street’s consensus estimate for Facebook’s third quarter calls for sales of $29.57 billion and earnings of $3.19 a share, according to FactSet. Analysts forecast that monthly active users hit 2.92 billion during the quarter, and predict that Facebook had 1.93 billion daily active users.\n“We expect Q3 results/outlook probably a bit better than Snap’s, with the company already acknowledging targeting headwinds, and more proactively developing tools to help with measurement and attribution,” Baird analyst Colin Sebastian wrote on Monday.\nThere’s a lot more news swirling around Facebook, with the company mulling changing its name, The Verge reports. (Barron’s was unable to corroborate The Verge’s report, which cites one anonymous source.) Earlier this month, whistleblower Frances Haugen’s damaging testimony about internal data and documents she submitted to lawmakers, regulators, and journalists seemed to drum up more support in Washington, D.C. for reining in the company. What steps, if any, lawmakers will take is unclear.\nIn a statement posted on Twitter, Facebook’s policy communications director Andy Stone said the company does not agree with many of Haugen’s characterizations of the issues she testified about, but called on lawmakers to make a standard set of rules for the internet.\nInvestors might wonder if a potential name change for Facebook is linked to a string of controversies in recent years about user data and its app’s potential influence on political polarization.On the flip side, the company is much more than its social network bearing the same name: It also owns Instagram, WhatsApp, and virtual reality headset maker Oculus.\nBeyond the company’s Monday earnings call, investors will be able to hear from Facebook CEO Mark Zuckerberg on Oct. 28, when he is slated to speak during the company’s virtual Facebook Connect event.Zuckerberg is set to discuss Facebook’s interest in the metaverse, a theorized next evolution of the internet, in which users socialize, shop, and consume entertainment in always-online virtual worlds.\nThe metaverse has been on Facebook’s radar for some time: The company bought Oculus in 2014, and during the company’s July conference call, Zuckerberg said building the metaverse was the company’s long-term aspiration. But Facebook isn’t the only company trying to build the metaverse, with upstarts in the videogame business like closely held Epic Games’ Fortnite,Roblox (RBLX), and Microsoft’s (MSFT) Minecraft all breaking ground on such online experiences.","news_type":1},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":896796196,"gmtCreate":1628604300915,"gmtModify":1631891608902,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>to be fair, the movement up yesterday was much faster than the movement down today. Its pretty well-supported already.","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>to be fair, the movement up yesterday was much faster than the movement down today. Its pretty well-supported already.","text":"$Moderna, Inc.(MRNA)$to be fair, the movement up yesterday was much faster than the movement down today. Its pretty well-supported already.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896796196","isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":876983815,"gmtCreate":1637249059818,"gmtModify":1637249059903,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>Keybanc analyst John Vinh maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Piper Sandler analyst Harsh Kumar maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Mizuho analyst Vijay Rakesh maintained Nvidia with a Buy rating and raised the price target from $235 to $335.Raymond James analyst Chris Caso maintained Nvidia with a Strong Buy rating and raised the price target from $225 to $365.Needham analyst Rajvindra Gill maintained Nvidia with a Buy rating and raised the price target from $245 to $400.Truist Securities analyst William Stein maintained Nvidia with a Buy rating and raised the price target from $360 to $389.","listText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>Keybanc analyst John Vinh maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Piper Sandler analyst Harsh Kumar maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Mizuho analyst Vijay Rakesh maintained Nvidia with a Buy rating and raised the price target from $235 to $335.Raymond James analyst Chris Caso maintained Nvidia with a Strong Buy rating and raised the price target from $225 to $365.Needham analyst Rajvindra Gill maintained Nvidia with a Buy rating and raised the price target from $245 to $400.Truist Securities analyst William Stein maintained Nvidia with a Buy rating and raised the price target from $360 to $389.","text":"$NVIDIA Corp(NVDA)$Keybanc analyst John Vinh maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Piper Sandler analyst Harsh Kumar maintained Nvidia with an Overweight rating and raised the price target from $260 to $350.Mizuho analyst Vijay Rakesh maintained Nvidia with a Buy rating and raised the price target from $235 to $335.Raymond James analyst Chris Caso maintained Nvidia with a Strong Buy rating and raised the price target from $225 to $365.Needham analyst Rajvindra Gill maintained Nvidia with a Buy rating and raised the price target from $245 to $400.Truist Securities analyst William Stein maintained Nvidia with a Buy rating and raised the price target from $360 to $389.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876983815","isVote":1,"tweetType":1,"viewCount":779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873545103,"gmtCreate":1636968096275,"gmtModify":1636968096405,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>lock in profits now and buy back later?&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>lock in profits now and buy back later?&nbsp;","text":"$Tesla Motors(TSLA)$lock in profits now and buy back later?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873545103","isVote":1,"tweetType":1,"viewCount":888,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":898432628,"gmtCreate":1628516705664,"gmtModify":1631893495576,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>time for the buyers to swallow up the sellers. Let's ride the coat tails of biontech today!&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>time for the buyers to swallow up the sellers. Let's ride the coat tails of biontech today!&nbsp;","text":"$Moderna, Inc.(MRNA)$time for the buyers to swallow up the sellers. Let's ride the coat tails of biontech today!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/898432628","isVote":1,"tweetType":1,"viewCount":289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":602139844,"gmtCreate":1638979161421,"gmtModify":1638979161658,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>&nbsp;tesla is now grandmother stock","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>&nbsp;tesla is now grandmother stock","text":"$Tesla Motors(TSLA)$ tesla is now grandmother stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/602139844","isVote":1,"tweetType":1,"viewCount":804,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":889727157,"gmtCreate":1631181654079,"gmtModify":1631886289175,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>stock with biggest loss on my portfolio but still holding cos its a favourite company&nbsp;","listText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>stock with biggest loss on my portfolio but still holding cos its a favourite company&nbsp;","text":"$Visa(V)$stock with biggest loss on my portfolio but still holding cos its a favourite company","images":[{"img":"https://static.tigerbbs.com/1ab164f587b7fc0ffc2b2239602d55c5","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/889727157","isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":875947064,"gmtCreate":1637597147175,"gmtModify":1637597147261,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>is it going to hold?&nbsp;","listText":"<a href=\"https://laohu8.com/S/FB\">$Meta Platforms, Inc.(FB)$</a>is it going to hold?&nbsp;","text":"$Meta Platforms, Inc.(FB)$is it going to hold?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/875947064","isVote":1,"tweetType":1,"viewCount":790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863215920,"gmtCreate":1632396768160,"gmtModify":1632800702794,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"Buy the dip!&nbsp;","listText":"Buy the dip!&nbsp;","text":"Buy the dip!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/863215920","repostId":"1190658591","repostType":4,"isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":605376625,"gmtCreate":1639123301077,"gmtModify":1639123301752,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"So 7%","listText":"So 7%","text":"So 7%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605376625","repostId":"1139831281","repostType":4,"isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":882041744,"gmtCreate":1631633979488,"gmtModify":1631887403737,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CROX\">$Crocs(CROX)$</a>&nbsp;wth is going on","listText":"<a href=\"https://laohu8.com/S/CROX\">$Crocs(CROX)$</a>&nbsp;wth is going on","text":"$Crocs(CROX)$ wth is going on","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/882041744","isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812557091,"gmtCreate":1630596423813,"gmtModify":1631886289287,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>&nbsp;this might be why... Just need the world to start accept the adjusted fees. When people realise the lack of convenience from not using visa, adoption will return, I hope!&nbsp;Amazon.com.au encourages customers to stop using their Visa cardThe Australian marketplace will from the start of November add a 0.5% surcharge to purchases made with a Visa card.","listText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>&nbsp;this might be why... Just need the world to start accept the adjusted fees. When people realise the lack of convenience from not using visa, adoption will return, I hope!&nbsp;Amazon.com.au encourages customers to stop using their Visa cardThe Australian marketplace will from the start of November add a 0.5% surcharge to purchases made with a Visa card.","text":"$Visa(V)$ this might be why... Just need the world to start accept the adjusted fees. When people realise the lack of convenience from not using visa, adoption will return, I hope! Amazon.com.au encourages customers to stop using their Visa cardThe Australian marketplace will from the start of November add a 0.5% surcharge to purchases made with a Visa card.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/812557091","isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899122018,"gmtCreate":1628170488934,"gmtModify":1631893495599,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>with earnings beat and out of the way, no more speculation but up!!&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>with earnings beat and out of the way, no more speculation but up!!&nbsp;","text":"$Moderna, Inc.(MRNA)$with earnings beat and out of the way, no more speculation but up!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899122018","isVote":1,"tweetType":1,"viewCount":91,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804016474,"gmtCreate":1627911917298,"gmtModify":1631893495631,"author":{"id":"3579088083036701","authorId":"3579088083036701","name":"7bd61add","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3579088083036701","idStr":"3579088083036701"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>&nbsp;330 tonight","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>&nbsp;330 tonight","text":"$Moderna, Inc.(MRNA)$ 330 tonight","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/804016474","isVote":1,"tweetType":1,"viewCount":717,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}